Cliff Asness’s Kyverna Therapeutics KYTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$111K Buy
+16,380
New +$129K ﹤0.01% 3975
2025
Q4
– Sell
-13,542
Closed -$81.3K – 3658
2025
Q3
$81.3K Sell
13,542
-86,616
-86% -$346K ﹤0.01% 3387
2025
Q2
$307K Buy
100,158
+29,101
+41% +$72K ﹤0.01% 2864
2025
Q1
$137K Buy
+71,057
New +$210K ﹤0.01% 2957

Other funds holding KYTX

Cliff Asness's KYTX Position: Q3 2026 in Review

Cliff Asness opened a new position in Kyverna Therapeutics (KYTX) in Q3 2026: 16,380 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #3975 among its holdings. This is a return to the name: Cliff Asness previously reported a position in KYTX as recently as Q3 2025.

Cliff Asness first reported a position in KYTX in Q1 2025 and has held it in 4 quarters since. The position peaked at $307K in Q2 2025. 128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.

  • Cliff Asness held 16,380 shares of Kyverna Therapeutics worth $111K as of Q3 2026.
  • Kyverna Therapeutics was a new Cliff Asness position in Q3 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #3975 holding.
  • Cliff Asness first reported a position in Kyverna Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Cliff Asness's Kyverna Therapeutics position peaked at $307K in Q2 2025.
  • 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.